高通量血液透析及高通量血液透析滤过对血脂代谢的影响被引量：2

Effect of high flux hemodialysis and high flux hemodiafiltration on lipid metabolism in maintenance hemodialysis patients

下载PDF

导出

摘要目的观察高通量血液透析及高通量血液透析滤过对血脂代谢的影响,探索有益于改善维持性血液透析患者血脂代谢紊乱的血液透析模式,指导临床应用。方法将70名维持性血液透析1年以上,并且病情稳定的患者,随机分为高通量血液透析组(high flux hemodialysis,HFHD组)和高通量血液透析滤过组(high flux hemodiafiltration,HFHDF组),治疗6个月,检测两种血液透析模式应用前后血脂(TC、TG、LDL、VLDL、HDL)水平的变化。结果治疗6个月后,HFHDF组TC、TG、LDL、VLDL较治疗前均降低(P<0.05),HDL升高(P<0.05);HFHDF组TC、TG、LDL、VLDL较HFHD组降低,HDL较HFHD组升高(P<0.05)。结论高通量血液透析滤过较高通量血液透析更能有效改善维持性血液透析患者血脂代谢,具有临床推广意义。 Objective： To observe the effect of high flux hemodialysis and high flux hemodiafiltration on lipid metabolism in maintenance hemodialysis patients,and to explore the mode of hemodialysis for improving dyslipidemia in maintenance hemodialysis patients to guide clinical application. Methods： Seventy patients undergone hemodialysis at least one year in stabilization were randomly divided into two groups： high flux hemodialysis group and high flux hemodiafiltration group. The treatment lasted for 6 months. Blood lipid（ TC,TG,LDL,VLDL and HDL） were examined before and after the treatment in the two groups. Results： After 6 months,the levels of TC,TG,LDL and VLDL of high flux hemodiafiltration group were significantly lower than before（ P 0. 05）,the level of HDL was significantly higher than before; Compared with high flux hemodialysis,the levels of TC,TG,LDL and VLDL were significantly lower（ P 0. 05）,the levels of HDL were significantly higher（ P 0. 05）. Conclusion： High flux hemodiafiltration is more effective than high flux hemodialysis in lipid metabolism in maintenance hemodialysis patients,which is valuable for clinical application.

作者郭劲余蕾马春荣陈雷

机构地区合肥市第一人民医院蜀山分院肾内科

出处《泰山医学院学报》 CAS 2014年第3期188-190,共3页 Journal of Taishan Medical College

关键词高通量血液透析高通量血液透析滤过血脂代谢 high flux hemodialysis high flux hemodiafiltration lipid metabolism

分类号 R459.5 [医药卫生—治疗学]

引文网络
相关文献

参考文献1

1ElZbieta KIMAK,Magdalena HALABI,Iwona BARANOWICZ-GASZCZYK.Relationships between serum lipid,lipoprotein,triglyceride-rich lipoprotein,and high-density lipoprotein particle concentrations in post-renal transplant patients[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2010,11(4):249-257. 被引量：5

二级参考文献28

1Brinton, E.A., Eisenberg, S., Breslow, J.L., 1994. Human HDL cholesterol levels are determinate by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arteriosclerosis, Thrombosis, and Vascular Biology, 14(5):707-720.
2Chan, D.C., Chen, M.M., Ooi, M.M., Watts, G.F., 2008. An ABC of apolipoprotein CII]: a clinically useful new cardiovascular risk factor? International Journal of Clinical Practice, 62(5):799-809. [doi:10.11111].1742-1241.2007.01678.x].
3Contois, J.H., McNamara, J.R., Lammi-Keefe, C.J., Wilson, P.W., Massov, Y., Schaefer, E.J., 1996. Reference intervals for apolipoprotein AI with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clinical Chemistry, 42(4): 507-514.
4Fellstrom, B., 2001. Risk factors for and management of post-transplantation cardiovascular disease. BioDrugs, 15(4):261-278. [doi:10.2165/00063030-200115040-00006].
5Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clinical Chemistry, 18(6):499-502.
6Ghaznavi, R., Zahmatkesh, M., Kadhodaee, M., Mahdavi- Mazdeh, M., 2007. Cyclosporine effects on the antioxi- dant capacity of rat renal tissues. Transplantation Proceedings, 39(4):866-867. [doi: 10.1016/j.transproceed. 2007.02.039].
7Gou, L., Fu, M., Xu, Y., 2005. Alterations of HDL subclasses in endogenous hypertriglyceridemia. American Heart Journal, 150(5):1039-1045. [doi:10.1016/j.ahj.2005.02.0321.
8Harchaoui, K.E.I., Arsenault, B.A., Franssen, R., Despres, J.P., Hovingh, G.K., Stroes, E.S., Otvos, J.D., Wareham, N.J., Kastelein, J.J., Khaw, K.T., et al., 2009. High-density lipoprotein particle size and concentration and coronary risk. Annales of Internal Medicine, 150(2):84-93.
9Jia, L., Long, S., Fu, M., Yah, B., Tian, Y., Xu, Y., Gou, L.,2006. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein ratio, and high-density lipoprotein subclasses. Metabolism, 55(9):1141-1148. [doi:10.1016/j.metaboh 2006.04.004].
10Jia, L., Wu, X., Fu, M., Xu, Y., Tian, Y., Tian, H., Tian, L., 2007. Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects. Clinica Chimica Acta, 383(1-2):65-72. [doi: 10.1016/j.cca 2007.04.017].